TAT-0002

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTAT-0002
Drug Alias Namesmall-molecule telomerase activators (Geron)small-molecule telomerase activators (TA Therapeutics)small-molecule telomerase activators (Geron/ Biotechnology Research)GRN-139951GRN-665 +[10] 
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionTelomerase activators
TargetsTelomerase
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHong Kong
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotechnology Research Corp LtdTA Therapeutics LtdGeron Corp
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary FibrosisHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A